Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chantal Mathieu

Showing results (371-380 of 626) with videos related to

Pageof 63
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 15, 2018
Investigating the Association Between Baseline Characteristics (HbA1c and Body Mass Index) and Clinical Outcomes of Fast-Acting Insulin Aspart in People with Diabetes: A Post Hoc AnalysisKeith Bowering, Helena W Rodbard, David Russell-Jones, et al.
Fertility and Sterility|June 9, 2006
Increased peritoneal and endometrial gene expression of biologically relevant cytokines and growth factors during the menstrual phase in women with endometriosisCleophas M Kyama, Lutgart Overbergh, Sophie Debrock, et al.
Lancet (London, England)|October 20, 2023
Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trialDavid Russell-Jones, Tetsuya Babazono, Roman Cailleteau, et al.
Acta Clinica Belgica|May 5, 2016
Long-term effects of gastric bypass surgery on psychosocial well-being and eating behavior: not all that glitters is goldRoman Vangoitsenhoven, Pascal Frederiks, Brecht Gijbels, et al.
Diabetologia|February 28, 2025
Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes affirms markers of diseaseRobert Moulder, M Karoliina Hirvonen, Tommi Välikangas, et al.
Immunology Letters|July 6, 2010
Murine bone marrow chimeras developing autoimmunity after CTLA-4-blockade show an expansion of T regulatory cells with an activated cytokine profileLien De Somer, Sabine Fevery, Dominique M A Bullens, et al.
Lancet (London, England)|March 15, 2011
Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trialBernard Zinman, Greg Fulcher, Paturi V Rao, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|May 14, 2013
Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countriesClaes-Göran Ostenson, Stephan Matthaei, Matthew Reaney, et al.
Clinicoeconomics and Outcomes Research : CEOR|July 23, 2013
Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE studyUrpo Kiiskinen, Stephan Matthaei, Matthew Reaney, et al.
Cell Death & Disease|April 7, 2019
Cytokine-induced translocation of GRP78 to the plasma membrane triggers a pro-apoptotic feedback loop in pancreatic beta cellsSaurabh Vig, Mijke Buitinga, Dieter Rondas, et al.
Pageof 63

Showing results (371-380 of 626) with videos related to

Sort By:
Pageof 63
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 15, 2018
Investigating the Association Between Baseline Characteristics (HbA1c and Body Mass Index) and Clinical Outcomes of Fast-Acting Insulin Aspart in People with Diabetes: A Post Hoc AnalysisKeith Bowering, Helena W Rodbard, David Russell-Jones, et al.
Fertility and Sterility|June 9, 2006
Increased peritoneal and endometrial gene expression of biologically relevant cytokines and growth factors during the menstrual phase in women with endometriosisCleophas M Kyama, Lutgart Overbergh, Sophie Debrock, et al.
Lancet (London, England)|October 20, 2023
Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trialDavid Russell-Jones, Tetsuya Babazono, Roman Cailleteau, et al.
Acta Clinica Belgica|May 5, 2016
Long-term effects of gastric bypass surgery on psychosocial well-being and eating behavior: not all that glitters is goldRoman Vangoitsenhoven, Pascal Frederiks, Brecht Gijbels, et al.
Diabetologia|February 28, 2025
Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes affirms markers of diseaseRobert Moulder, M Karoliina Hirvonen, Tommi Välikangas, et al.
Immunology Letters|July 6, 2010
Murine bone marrow chimeras developing autoimmunity after CTLA-4-blockade show an expansion of T regulatory cells with an activated cytokine profileLien De Somer, Sabine Fevery, Dominique M A Bullens, et al.
Lancet (London, England)|March 15, 2011
Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trialBernard Zinman, Greg Fulcher, Paturi V Rao, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|May 14, 2013
Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countriesClaes-Göran Ostenson, Stephan Matthaei, Matthew Reaney, et al.
Clinicoeconomics and Outcomes Research : CEOR|July 23, 2013
Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE studyUrpo Kiiskinen, Stephan Matthaei, Matthew Reaney, et al.
Cell Death & Disease|April 7, 2019
Cytokine-induced translocation of GRP78 to the plasma membrane triggers a pro-apoptotic feedback loop in pancreatic beta cellsSaurabh Vig, Mijke Buitinga, Dieter Rondas, et al.
Pageof 63